i can't find the relationship between sinopharm hunan chengde and sinopharm. i believe they are 2 different companies.kanger is just goreng stock. good luck.
The sinopharm hunan joint-venture with GI Healthcare Resources Sdn Bhd. The owners of GI Healthcare Resource Sdn. Bhd. are Tan Sri Lim Yew Loong (LYL Group), Tan Sri Leong Hoy Kum (Mah Sing), Sim Guan Yu and Rosli Dahlan (Lawyer).
Tan Sri Leong Hoy Kum is the founder of Mah Sing. It look like Mah Sing is in the Covid-19 vaccine loop. You all may take a look of the news from the following link.
The 10,000 doses of Sinopharm Vaccine to be sponsored is by GI Healthcare Resources Sdn Bhd is merely to fulfill their corporate social responsibility (CSR) to donate 10,000 doses of Sinopharm Vaccine for emergency use of frontliners only, NOT FOR GENERAL PUBLIC. They will not be distributing the vaccines.
Please note that Emergency use is NOT the same as full approval. It is merely a form of conditional authorization of the vaccine to be used by specific targeted groups such as frontliners and vulnerable groups ONLY (and NOT FOR GENERAL PUBLIC). Emergency use authorization is just based on interim clinical trial results (pending the completion of phase III clinical trial). Once the phase III clinical trial of Sinopharm Vaccine is completed very soon, the complete clinical data of the vaccine can then be submitted to the Ministry of Health (MOH) for evaluation and approval. Upon receiving FULL APPROVAL of the vaccine by Ministry of Health (MOH), the vaccine can then be used for the GENERAL PUBLIC.
Kanger in collaboration with Zuellig Pharma and Kstar will be the ones distributing the vaccines to private and government hospitals and clinics.
KJ announced today Malaysia to pay upfront 94 Million under COVAX vaccine program. this is part of WHO worldwide initiative vaccine to ensure all countries has their vaccines
Yeah yeah we expect result like gloves profit billion billion but bloodbath still... Buaya want u up even u loss also can up, buaya want you down even u earn billion also can drop la... Wake up la, now umno buaya want it up u dunno mei
Today got 1,000 lot last minute sapu all. Must be Umno buaya la. Sure got more news in the pipe line to push up the price. Anyway, year to date profit looks better than last year.
Share price rm5.7+ but profit Rm1.4mil, laugh dies ppl. Somemore so many vaccine retailer go naysaying top4 counters. Pls pray bottling business will realize,else next qr sure tapao. Luckily Top4 got provide donation for u all vaccine counter, else really pity la.
Hahaha see these comments really make me laugh, is like go top glove counter see they say QR very good 1 billions blah blah blah tomorrow sure limit up, and then next day bloodbath... Laugh die me these noob really dun understand who is controlling the market...
If you think buy share is as simple as finding best profit earning company, then everyone just go buy that top 10 earning company then everyone will earn money no people will lose money in the stock market lor... Jokers hahaha
Tomorrow my tears will fall. Should not have bought high. Lousy counter with all fake hopes of vaccine. Millions of revenue with a profit of 1 million so when vaccibe comes out revenue 1.28 billion and profit 2 .88 million. Die standing.
Pity those gloves counter, in blood bath for few months until now still cannot recover.. Play by the big buaya, hahaha... Now big buaya rhb tell u even vaccine out will generate 18 billions gloves to use, faster go chase and help buaya push high the price again... Again and again buaya give u good news again and again they sell it high to you, no ending by playing by these buaya
On 14th September, the Group’s wholly owned manufacturing subsidiary Xepa-Soul Pattinson (M) Sdn Bhd secured renewal of its GMP status with the National Pharmaceutical Regulatory Authority (‘NPRA’) through a scheduled desktop audit. In the quarter, Apex Pharma Marketing Pte Ltd in Singapore increased its cold chain distribution capabilities with the expansion of its current 2-8 degrees C cold room and the acquisition of a -20 degrees C freezer room for pharmaceuticals, vaccines and biologics. Expansion of cold chain distribution capacity in Malaysia is scheduled for completion before the end of the current financial year. Review of Year To Date Performance versus Corresponding Period Last Year
Oxford scientists expect COVID-19 vaccine data by Christmas
University of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas, a key researcher said Thursday as he discussed the team's latest findings.
Worldwide covid cases hit 55 million. US, Brazil, India, France, Russia are the worst hit countries. President elect Joe Biden { taking over the Presidency in January} and WHO have aggressively pushing for a vaccine on or before end December usage. Something is better nothing {urmost priority protecting American lives for Joe Biden}
...usually dpharma/pharma moves together..means if dpharma break new high, pharma will follow...because the shark as insiders knows the reports isnt good so they dont push up the price and wait till the report....as you can see...dpharma almost at new high corner..but pharma only 5.5...1 ringgit away from 6.6 (high).... so after this report, once sell off completed....will up
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
NPRA1985
3,415 posts
Posted by NPRA1985 > 2020-11-18 23:51 | Report Abuse
Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns
https://edition.cnn.com/2020/11/18/health/pfizer-coronavirus-vaccine-safety/index.html